Related references
Note: Only part of the references are listed.MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer
John J. O'Shea et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
Timothy Beukelman et al.
ARTHRITIS AND RHEUMATISM (2012)
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
Laura Dell'Era et al.
VACCINE (2012)
Effective influenza vaccines for children
Angelika Banzhoff et al.
Human Vaccines & Immunotherapeutics (2012)
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
Karen Au et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
M. W. Heijstek et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
Takao Koike et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections
Daniel Tesfa et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
Ekaterina I. Alexeeva et al.
CLINICAL RHEUMATOLOGY (2011)
Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines
Jan Poolman et al.
EXPERT REVIEW OF VACCINES (2011)
Neutralization of Different Echovirus Serotypes by Individual Lots of Intravenous Immunoglobulin
Christina B. Planitzer et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice
Tzu-Chieh Weng et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
Challenges in Diagnosing Latent Tuberculosis Infection in Patients Treated with Tumor Necrosis Factor Antagonists
Edward C. Keystone et al.
JOURNAL OF RHEUMATOLOGY (2011)
Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
Timo Vesikari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
Hans-Peter Tony et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
J. D. Greenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
M. Mosca et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments
Laszlo Marodi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Effectiveness of Leflunomide in Patients with Juvenile Idiopathic Arthritis in Clinical Practice
Ivan Foeldvari et al.
JOURNAL OF RHEUMATOLOGY (2010)
Initiation of rheumatoid arthritis treatments and the risk of serious infections
Carlos G. Grijalva et al.
RHEUMATOLOGY (2010)
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
G. Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Long-Term Safety and Effectiveness of Etanercept in Children With Selected Categories of Juvenile Idiopathic Arthritis
E. H. Giannini et al.
ARTHRITIS AND RHEUMATISM (2009)
Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
F. Tubach et al.
ARTHRITIS AND RHEUMATISM (2009)
Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology
Jose Maria Aguado et al.
CLINICAL INFECTIOUS DISEASES (2009)
Autoimmunity in common variable immunodeficiency
Shradha Agarwal et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2009)
Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease
Noritaka Takatsu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept
S. Borte et al.
RHEUMATOLOGY (2009)
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression
Anselm Mak et al.
RHEUMATOLOGY (2009)
Methotrexate, rheumatoid arthritis and infection riskwhat is the evidence
Andrew McLean-Tooke et al.
RHEUMATOLOGY (2009)
Serum Immunoglobulins and Risk of Infection: How Low Can You Go?
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Recommendations for tuberculosis screening before initiation of TNF-α-inhibitor treatment in rheumatic diseases
R. Diel et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2009)
Nontuberculous Mycobacteria Infections and Anti-Tumor Necrosis Factor-α Therapy
Kevin L. Winthrop et al.
EMERGING INFECTIOUS DISEASES (2009)
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2008)
Pediatric Selective IgM Immunodeficiency
Marc F. Goldstein et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2008)
National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents
Sean D. Doherty et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Pneumocystis pneumonia in children receiving chemotherapy
Pinki Prasad et al.
PEDIATRIC BLOOD & CANCER (2008)
Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis
M. L. Burr et al.
RHEUMATOLOGY (2008)
Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis
N. Jung et al.
RHEUMATOLOGY (2008)
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom
Allison L. Smitten et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Johan Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis
S. Bernatsky et al.
RHEUMATOLOGY (2007)
Immunization in children and adolescents with rheumatic diseases
K. Minden et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2007)
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
Michael Weinblatt et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antirheumatic drugs and the risk of tuberculosis
Paul Brassard et al.
CLINICAL INFECTIOUS DISEASES (2006)
Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain
N Respaldiza et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
B cell non-Hodgkin's lymphoma: rituximab safety experience
A Mohrbacher
ARTHRITIS RESEARCH & THERAPY (2005)
Leflunomide or methotrexate for juvenile rheumatoid arthritis
E Silverman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection
WT Hughes et al.
CLINICAL INFECTIOUS DISEASES (2005)
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate
MC Genovese et al.
ARTHRITIS AND RHEUMATISM (2004)
A review of the varicella vaccine in immunocompromised individuals
AMC Sartori
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2004)
The small spleen:: Sonographic patterns of functional hyposplenia or asplenia
C Görg et al.
JOURNAL OF CLINICAL ULTRASOUND (2003)
Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency
PJ Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Share Paper
